Doctor profile · Federal record
Dr. Lane Neidig, MD
Dermatology Physician (CMS: Dermatology) · Annapolis, MD
- NPI 1851779573
- Accepts Medicare
- MIPS 87.7 / 100 · 2023
- 11 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2568A Riva RD Ste 102
Annapolis, MD 214017457
(410) 216-0993
fax (410) 237-6106
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- September 18, 2023
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Maryland #D0087259
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1851779573. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
722
Distinct HCPCS
10
Medicare allowed
$57,753
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 194 | 30 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 102 | 81 | $101 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 75 | 59 | $141 | |
11102 |
Biopsy of related skin growth, first growth | 63 | 58 | $88 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 63 | 63 | $122 | |
17000 |
Destruction of precancer skin growth, 1 growth | 60 | 47 | $50 | |
17110 |
Destruction of skin growth, 1-14 growths | 55 | 43 | $129 | |
11103 |
Biopsy of related skin growth, each additional growth | 47 | 28 | $56 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 47 | 47 | $181 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 16 | 13 | $62 |
In context: peer comparison
Among 6 peers in Annapolis Dermatology Physician, average services per provider: 292. This provider delivers 2.5× the peer median.Open Payments
Industry payments received
All-time total
$2,880
Transactions
118
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dermavant Sciences, INC. | 27 | $480.83 | |
| Genzyme Corporation | 11 | $336.65 | |
| Janssen Biotech, INC. | 16 | $328.64 | |
| Regeneron Healthcare Solutions, INC. | 12 | $314.37 | |
| Lilly USA, LLC | 13 | $261.99 | |
| Sun Pharmaceutical Industries INC. | 5 | $184.45 | |
| Novartis Pharmaceuticals Corporation | 8 | $150.60 | |
| Ucb, INC. | 4 | $108.09 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 4 | $108.03 | |
| Abbvie INC. | 4 | $105.13 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $83.44 | |
| Incyte Corporation | 4 | $79.52 | |
| Pfizer INC. | 3 | $68.02 | |
| Amgen INC. | 2 | $49.62 | |
| Elekta, INC. | 1 | $46.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
398
Patients
184
Total drug cost
$15,540
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 93 | 32 | $2,669 |
| Triamcinolone Acetonide | Generic | 76 | 47 | $1,141 |
| Mometasone Furoate | Generic | 39 | 20 | $1,074 |
| Clindamycin Phosphate | Generic | 30 | 13 | $1,492 |
| Clobetasol Propionate | Generic | 29 | 15 | $4,197 |
| Betamethasone Dipropionate | Generic | 24 | 15 | $1,802 |
| Hydrocortisone | Generic | 23 | 14 | $123 |
| Ammonium Lactate | Generic | 21 | 0 | $712 |
| Doxycycline Hyclate | Generic | 20 | 15 | $454 |
| Mupirocin | Generic | 20 | 13 | $172 |
Frequently asked questions
What is Dr. Lane Neidig's medical specialty?
Dr. Lane Neidig practices Dermatology Physician in Annapolis, MD.
Where does Dr. Lane Neidig practice?
Dr. Lane Neidig practices at 2568A Riva RD Ste 102, Annapolis, MD 214017457. Office phone: 4102160993.
What is Dr. Lane Neidig's NPI?
Dr. Lane Neidig's National Provider Identifier (NPI) is 1851779573, issued by NPPES.
Does Dr. Lane Neidig accept Medicare assignment?
Yes. Dr. Lane Neidig accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lane Neidig commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.